Markets:

Overview

News

Currencies

International

Treasuries

Field Trip Health Ltd. - Common Shares (NQ:FTRP)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Aug 16, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Field Trip Health Ltd. - Common Shares

< Previous 1 2 3 4 5 6 7 Next >

3 Psychedelic Stocks for Potential Out-of-This-World Gains ↗

November 18, 2021

Psychedelic drugs could be a major game-changer when it comes to treating mental illness. All as psilocybin, LSD, and MDMA show progress.

Via InvestorPlace

Compass Pathways Phase II Results: A Disappointment For Some, An Opportunity For Others ↗

November 11, 2021

Compass Pathways reported

Via Talk Markets

Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent ↗

October 26, 2021

The Week In Psychedelics

Via Benzinga

Psychedelics Industry Moving Full-Speed Ahead, When Will Stocks Catch Up? ↗

October 23, 2021

The psychedelic drug industry is advancing by leaps and bounds, but the stocks have been sliding. Why this disconnect won't last.

Via Talk Markets

Psychedelics Discussed At Benzinga Cannabis Capital Conference: Growth Opportunities, Mental Health & Pharma ↗

October 19, 2021

Ronan Levy, co-founder and executive chairman of Field Trip Ltd (NASDAQ: FTRP), a company developing a network of psychedelics-assisted therapy clinics; Doug Drysdale, CEO,...

Via Benzinga

Topics Cannabis

Field Trip Stock Could Climb 300% In One Year ↗

September 02, 2021

On Wednesday, HC WainWright began coverage of Field Trip Health (NASDAQ:

Via Benzinga

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation ↗

October 18, 2021

The Week In Psychedelics

Via Benzinga

This Company Just Extended its Reach into the United Kingdom by Opening its First Ketamine Therapy Clinic ↗

October 18, 2021

Photo by cottonbro from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner...

Via Benzinga

Forget The Hype: The Psychedelic Stocks Sector Went Down In The Third Quarter Of 2021 ↗

October 15, 2021

Despite the prevailing hype, the psychedelic sector went down considerably last quarter (July through September) and has gone down even further so far this month.

Via Talk Markets

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are ↗

October 13, 2021

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...

Via Benzinga

This Psychedelic Therapies Stock Has A Better One-Year Return Than Nio, AMD, Nvidia And GE ↗

October 13, 2021

Field Trip Health Ltd (NASDAQ: FTRP) is a global leader in psychedelic therapies, and over the past year, bringing eye-popping gains to investors’ portfolios. Since October...

Via Benzinga

Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction ↗

October 04, 2021

The Week In Psychedelics:

Via Benzinga

September Summary: Cannabis-Based Vs. Psychedelic Compounds-Based Drug Stock Performances ↗

October 01, 2021

Which index out-performed in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?

Via Talk Markets

6 Psychedelic Stocks With Buy Rating: Why Are They Good Investments? ↗

October 01, 2021

This article by Jason Najum was originally published on

Via Benzinga

Elon Musk Acknowledges Therapeutic Potential Of Psychedelic Drugs: Will This Impact The Markets? ↗

September 29, 2021

Elon Musk expressed his support for the therapeutic potential of psychedelic drugs. The Space X and

Via Benzinga

The Three Psychedelics ETFs: Which Is The Best Fit For Your Portfolio? ↗

September 21, 2021

We compare and contrast the three psychedelic drug ETFs and assess which investor needs each addresses.

Via Talk Markets

Cannabis Drug Stocks Have Mirrored Performance Of Psychedelic Drug Stocks To Date In September ↗

September 20, 2021

Which index has outperformed so far in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?

Via Talk Markets

Topics Cannabis

Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics ↗

September 13, 2021

Last Week In Psychedelics:

Via Benzinga

Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry? ↗

September 09, 2021

By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate...

Via Benzinga

Psyched: Field Trip Gets $20 Price Target, DEA Seeks To Increase Psilocybin Production Limits, Synthesis Closes $7.25M Series A ↗

September 07, 2021

Contents

Via Benzinga

Psychedelic Drug Industry Report Card For 2021 ↗

September 01, 2021

In assessing the psychedelic drug industry, a primary focus for investors is drug development.

Via Talk Markets

54 Biggest Movers From Yesterday ↗

September 02, 2021

Gainers Focus Universal Inc. (NASDAQ: FCUV) shares climbed 278% to close at $19.28 on Wednesday. The stock started trading on Nasdaq Capital Market yesterday. Sequential Brands...

Via Benzinga

Why Field Trip Health Shares Are Trading Higher Today ↗

September 01, 2021

Field Trip Health (NSADAQ: FTRP) shares are trading higher after HC Wainwright & Co initiated coverage on the stock with a Buy rating and a $20 price target. The firm said it...

Via Benzinga

38 Stocks Moving In Wednesday's Mid-Day Session ↗

September 01, 2021

Gainers Focus Universal Inc. (NASDAQ: FCUV) shares jumped 108.2% to $10.62. The stock started trading on Nasdaq Capital Market yesterday. Sequential Brands Group, Inc. (NASDAQ:...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2021 ↗

September 01, 2021

Upgrades For Chatham Lodging Trust (NYSE:

Via Benzinga

21 Stocks Moving in Wednesday's Pre-Market Session ↗

September 01, 2021

Gainers GBS Inc. (NASDAQ: GBS) rose 72.3% to $5.58 in pre-market trading. The company markets saliva test for diabetes management and previously announced collaboration on covid-...

Via Benzinga

75 Biggest Movers From Yesterday ↗

August 04, 2021

Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares climbed 68.1% to close at $58.25 on Tuesday after the company announced that the it has received approval for a...

Via Benzinga

Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected ↗

August 02, 2021

Last week in Psychedelics:

Via Benzinga

Field Trip Health Debuts On Nasdaq With Average Performance, Looks To Expand Footprint Of Psychedelics Clinics ↗

July 29, 2021

Field Trip Health (TSX:FTRP) (NASDAQ:

Via Benzinga

Another Psychedelic Stock Debuts, As This One Sets Up In A Base ↗

July 29, 2021

Field Trip Health dipped in its first day on the Nasdaq, making it the latest psychedelics company to hit a big U.S. exchange.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Field Trip Health Ltd. - Common Shares (NQ:FTRP)

Headline News about Field Trip Health Ltd. - Common Shares

Starting at $3.75/week.

Subscribe Today